We believe the results will pave the way for a longer use in maintenance and increased penetration. Therefore we increase our daratumumab (Darzalex) peak sales forecast in multiple myeloma to 40 billion Danish crowns from 35 billion crowns and raise our target price to 1,100 crowns (1,025).
This page is about the voters of this citizen quote.
We're doing our best to make sure our content is useful, accurate and safe. If by any chance you spot an inappropriate comment while navigating through our website please use this form to let us know, and we'll take care of it shortly.
Share your thoughts on this citizen quote voters with the community:
Report Comment
We're doing our best to make sure our content is useful, accurate and safe.
If by any chance you spot an inappropriate comment while navigating through our website please use this form to let us know, and we'll take care of it shortly.
Attachment
You need to be logged in to favorite.
Log In